Total and High-Molecular-Weight Adiponectin and Risk of Incident Diabetes in Older People

OBJECTIVE To delineate the associations of total adiponectin, high-molecular-weight (HMW) adiponectin, and the HMW-to-total adiponectin ratio with diabetes in older adults. RESEARCH DESIGN AND METHODS Total and HMW adiponectin were measured in a population-based study of older adults. The relations of total adiponectin, HMW adiponectin, and their ratio with incident diabetes (n = 309) were assessed in 3,802 individuals. RESULTS Total and HMW adiponectin were highly correlated (r = 0.94). Analysis using cubic splines revealed that the associations between total and HMW adiponectin and new-onset diabetes were not linear. Specifically, after adjustment for confounders, there were similar inverse relationships for total (hazard ratio per SD 0.49 [95% CI 0.39–0.63]) and HMW adiponectin (0.42 [0.32–0.56]) with diabetes up to values of 20 and 10 mg/L, respectively, above which the associations plateaued. These associations persisted after adjustment for potential mediators (blood pressure, lipids, C-reactive protein, and homeostasis model assessment of insulin resistance [HOMA-IR]). There was, however, evidence of interaction by HOMA-IR in the lower range of adiponectin, with stronger inverse associations among insulin-sensitive than insulin-resistant participants. HMW-to-total adiponectin ratio showed a linear adjusted association with outcome, but this was abolished by inclusion of mediating variables. CONCLUSIONS In this older cohort, increasing concentrations of total and HMW adiponectin were associated with comparably lower risks of diabetes, but these associations leveled off with further increases above concentrations of 20 and 10 mg/L, respectively. The more pronounced risk decreases at the lower range among participants without insulin resistance support a role for adiponectin that is independent of baseline hyperinsulinemia, but this will require further investigation.

[1]  C. Mantzoros,et al.  Effects of leptin and adiponectin on pancreatic β-cell function. , 2011, Metabolism: clinical and experimental.

[2]  S. Kritchevsky,et al.  Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  W. Rathmann,et al.  Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study , 2011, Diabetologia.

[4]  J. Pankow,et al.  High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. , 2010, The Journal of clinical endocrinology and metabolism.

[5]  D. Mozaffarian,et al.  Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older Adults , 2010 .

[6]  D. Mozaffarian,et al.  Association between adiposity in midlife and older age and risk of diabetes in older adults. , 2010, JAMA.

[7]  L. Fried,et al.  Long‐Term Function in an Older Cohort—The Cardiovascular Health Study All Stars Study , 2009, Journal of the American Geriatrics Society.

[8]  Desmond E. Williams,et al.  Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006 , 2009, Diabetes Care.

[9]  F. Hu,et al.  Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in Women , 2008, Annals of Internal Medicine.

[10]  N. Sattar,et al.  Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. , 2008, The Journal of clinical endocrinology and metabolism.

[11]  Frank A Sloan,et al.  The growing burden of diabetes mellitus in the US elderly population. , 2008, Archives of internal medicine.

[12]  M. Lazar,et al.  Mechanisms of obesity-associated insulin resistance: many choices on the menu. , 2007, Genes & development.

[13]  T. Funahashi,et al.  Associations of Adiponectin Levels With Incident Impaired Glucose Metabolism and Type 2 Diabetes in Older Men and Women , 2006, Diabetes Care.

[14]  A. Nakashima,et al.  Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[16]  S. Cummings,et al.  Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1. , 2006, Archives of internal medicine.

[17]  John A Wagner,et al.  Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.

[18]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[19]  L. Kuller,et al.  Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.

[20]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[21]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[22]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[23]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[24]  J. Stockman Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis , 2011 .

[25]  D. Mozaffarian,et al.  Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women. , 2011, American journal of epidemiology.

[26]  C. Mantzoros,et al.  Adiponectin in insulin resistance: lessons from translational research. , 2010, The American journal of clinical nutrition.

[27]  Stefan Sperlich,et al.  Generalized Additive Models , 2014 .

[28]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.

[29]  浜田賀代子,et al.  老年期痴呆患者のスクリーニングにおけるThe modified mini-mental state (3MS) examination日本語版の有用性 , 1992 .